Aspen Pharmacare Holdings Ltd (APN)
Johannesburg Exchange · South Africa · prices in ZAC · close of 22 Oct 2026
Key indicators
| Last close | ZAC 15,868.00 |
|---|---|
| 52-week range | 9,070.00 – 16,621.00 |
| Return, 1 month / 3 months | +0.9% / +7.6% |
| Return, 1 year / 3 years | +58.7% / +2.2% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 38.0% |
| Worst drawdown (1 year) | -13.7% |
| Average daily value traded | 24,420.97M ZAC |
| Dividend yield | 1.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aspen Pharmacare Holdings is a pharmaceutical company based in South Africa. It develops, manufactures and supplies generic and branded prescription medicines, including anaesthetics, thrombosis treatments and other therapies, to hospitals, pharmacies and healthcare providers in many countries. The company also makes infant formula and nutritional products. Its manufacturing and commercial operations serve both public and private healthcare markets, with a portfolio spanning finished dosage forms and active pharmaceutical ingredients.
The shares are listed on the Johannesburg Exchange in South Africa under the code APN, and the price on this page is in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aspen Pharmacare Holdings Ltd (APN) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 15,868.00 on 22 October 2026.
Its price-based Market X-Ray is 78 out of 100 (a strong price profile), ranking 12 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 58.7% and over the last three months it rose 7.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.1% | ||
| From 52-week high | -3.5% | ||
| Momentum | 89 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 7.6% | ||
| 6-month return | 19.3% | ||
| 12-month return, skipping the last month | 57.2% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 38.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.7% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 24,420.97M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | 33 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.5% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.3% |
|---|---|
| 1 month | +0.9% |
| 3 months | +7.6% |
| 6 months | +19.3% |
| 1 year | +58.7% |
| 3 years | +2.2% |
| 5 years | −29.7% |
Signals
| 50-day / 200-day average | 15,330.52 / 13,904.24 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 476.13 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Oct 2026 | ZAC 232.0000 |
| 1 Oct 2025 | ZAC 211.0000 |
| 18 Sep 2024 | ZAC 359.0000 |
| 20 Sep 2023 | ZAC 342.0000 |
| 21 Sep 2022 | ZAC 326.0000 |
| 21 Sep 2021 | ZAC 262.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.